Chi-Med's Savolitinib: Overcoming Treatment Resistance in NSCLC

 
• By John Davis
  
Flower
Overcoming resistance is important in cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D